Enanta Pharmaceuticals to Present at the Wells Fargo Securities 2013 Healthcare Conference

Enanta Pharmaceuticals to Present at the Wells Fargo Securities 2013 Healthcare Conference

WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc., (NAS: ENTA) , a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present a corporate overview followed by a Q&A session and participate in a Hepatitis C panel discussion on June 18, 2013 at the Wells Fargo Securities 2013 Healthcare Conference in Boston, MA. The panel discussion will take place at 10:00 a.m. ET and the presentation will take place at 11:10 a.m. ET.

The panel discussion and presentation will be webcast live and a replay can be accessed by visiting the Investor homepage section of Enanta's website at www.enanta.com. A replay of the webcasts will be available following the presentations and will be archived for approximately 30 days.


About Enanta

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. Enanta is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV). These inhibitors include members of the direct acting antiviral (DAA) inhibitor classes - protease (partnered with AbbVie), NS5A (partnered with Novartis) and nucleotide polymerase - as well as a host-targeted antiviral (HTA) inhibitor class targeted against cyclophilin. Additionally, Enanta has created a new class of antibiotics, called Bicyclolides, for the treatment of multi-drug resistant bacteria, with a current focus on developing an intravenous and oral treatment for hospital and community MRSA (methicillin-resistant Staphylococcus aureus) infections.



Investor Contact
Enanta Pharmaceuticals, Inc.
Carol Miceli, 617-607-0710
cmiceli@enanta.com

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:

The article Enanta Pharmaceuticals to Present at the Wells Fargo Securities 2013 Healthcare Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Increase your money and finance knowledge from home

Understanding Stock Market Indexes

What does it mean when people say "the market is up 2%"?

View Course »

Reading a Stock Quote

Learn to read the ingredients of a stock.

View Course »

Add a Comment

*0 / 3000 Character Maximum